Latest Education News

IVE Group has inked a long-term marketing services agreement with Domino’s Pizza Enterprises and expanded its footprint through acquisitions of Impressu Print Group and Budget Mail Services.

Skin Elements Limited reports successful completion of key product evaluations and secures $2.5 million placement to fuel growth and commercialisation in 2026.

Complii FinTech Solutions reported a 4.9% year-on-year increase in annual recurring revenue, progressed a major CRM system upgrade, and secured a $1.217 million R&D rebate in Q1 FY26, while managing cash flow pressures.

Adherium Limited reports a strong quarter with a 55% increase in device shipments and groundbreaking clinical results from its iCARE study, alongside securing over $2.6 million in post-quarter funding.

KNeoMedia reports significant progress toward ASX reinstatement, driven by strategic capital raises and the expansion of its KneoScience platform into New York high schools, boosting potential revenue and student reach.

Victor Group Holdings reported $1.475 million revenue from cloud services in China but faced a $523,000 negative cash flow due to upfront project costs, with management expecting a turnaround next quarter.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

Mayfield Childcare Limited reported a 5% revenue increase and a 14% rise in underlying EBITDA for Q3 FY25, alongside a $2.4 million debt reduction and an extended borrowing facility. The company also ended a planned divestment and announced a new community partnership.

Celsius Resources reports steady progress on its Maalinao-Caigutan-Biyog copper-gold project, supported by promising drilling outcomes and critical bridge financing. The company also advances social and environmental initiatives while preparing for operational readiness.

Aspire Mining Limited reports significant progress on its Ovoot Coking Coal Project, securing exclusive marketing rights and aligning infrastructure development with government-backed transport projects.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

TrivarX has reported promising interim results from its US veteran-focused mental health trial using ECG technology, while progressing a strategic acquisition of novel brain tumor imaging IP to broaden its diagnostic portfolio.